Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Rituxan
Related studies linked through entity extraction aliases.
Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases
- Status
- TERMINATED
- Phase
- PHASE1
Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Randomized Double Cord Blood Transplant Study
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Rituxan in the Treatment of Polyneuropathies Associated With Serum IgM Autoantibodies
- Status
- UNKNOWN
- Phase
- PHASE2